Myasthenia Gravis Press Releases
New Orthostatic Hypotension Treatment Reduces Symptoms Without Causing High Blood Pressure
Tuesday, Apr 11, 2006
A drug traditionally used to treat myasthenia gravis shows potential benefit for reducing symptoms of orthostatic hypotension without raising blood pressure when people lie down, according to results of a double-blind, controlled clinical trial.
NINDS Funds Five Specialized Neuroscience Programs at Minority Institutions
Tuesday, Jan 18, 2000
The National Institute of Neurological Disorders and Stroke (NINDS), in collaboration with the National Center for Research Resources (NCRR) and the Office for Research on Minority Health (ORMH), recently awarded grants to five minority institutions under a new funding mechanism called Specialized Neuroscience Research Programs at Minority Institutions (SNRP).
Audrey S. Penn, M.D., Named NINDS Deputy Director
Friday, Mar 1, 1996
BETHESDA, MD - Audrey S. Penn, M.D., one of the nation's leading neurologists and a well-known scientist specializing in neuromuscular disease research, has been named Deputy Director of the National Institute of Neurological Disorders and Stroke (NINDS).
Study Shows IVIG Safe, Effective Treatment for Muscle Disease
Wednesday, Dec 29, 1993
Patients with a painful and debilitating muscle disease called dermatomyositis showed dramatic improvement on a treatment regimen of intravenous immune globulin (IVIG) during a recent double-blind, placebo-controlled trial. The study, which was conducted at the National Institute of Neurological Disorders and Stroke (NINDS), will be published in the December 30 issue of the New England Journal of Medicine.